{
    "code": "02003871",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02003871",
    "time": "2020-02-25 08:23:20",
    "許可證字號": "衛署藥輸字第003871號",
    "註銷狀態": "已註銷",
    "註銷日期": "88\/09\/22",
    "註銷理由": "未展延而逾期者",
    "製造許可登錄編號": "",
    "有效日期": "74\/07\/14",
    "發證日期": "64\/11\/21",
    "許可證種類": "製　劑",
    "舊證字號": "13004975",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00200387101",
    "中文品名": "安利維爾",
    "英文品名": "ALEVAIRE SOLUTION",
    "適應症": "肺、支氣管黏液分泌過多、過濃症",
    "劑型": "170內服液劑",
    "包裝": "瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "SODIUM BICARBONATE ( EQ TO SODIUM HYDROGEN CARBONATE), TYLOXAPOL (SUPERINONE)",
    "限制項目": "02輸　入",
    "申請商名稱": "0902101100  美商美國溫莎大藥廠股份有限公司台灣分公司",
    "申請商地址": "台北巿民生東路三段１５６號８樓之１之２之３",
    "主製造廠": [
        {
            "製造廠名稱": "FGB0128000  WINTHROP LAB. PRODUCTION DIV. OF STERLING-WINTHROP GROUP LTD.",
            "製造廠廠址": "NEWCASTLE-UPON-TYNE",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4008000700",
            "成分名稱": "SODIUM BICARBONATE ( EQ TO SODIUM HYDROGEN CARBONATE)",
            "含量描述": "2",
            "含量": "2.0000000000",
            "單位": "%"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4800003400",
            "成分名稱": "TYLOXAPOL (SUPERINONE)",
            "含量描述": "0.125",
            "含量": "0.1250000000",
            "單位": "%"
        }
    ]
}